Trials / Completed
CompletedNCT01625702
Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 138 (actual)
- Sponsor
- Peking University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To identify the correlation of CTCs with clinical prognosis in advanced/metastatic gastric cancer. Confirm the presence of CTCs are sensitive for monitoring response to chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CellSearch® CTC kit | Collect peripheral blood sample of 100 gastric cancer patients pre-chemotherapy treated with capecitabine/paclitaxel (XPa) and capecitabine/cisplatin (XP) and post two cycles of chemotherapy(response evaluation). Blood samples will be transferred to central lab to detect CTCs by Cellsearch kit. Tumor response evaluation will be performed after two cycles of chemotherapy by CT/MRI based on RECIST. Clinical data, including tumor stage, metastastic organ, chemotherapy regimen, objective response, progression free survival, overall survival, etc, will be collected according to study protocol. |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2014-07-01
- Completion
- 2015-12-01
- First posted
- 2012-06-21
- Last updated
- 2017-05-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01625702. Inclusion in this directory is not an endorsement.